UniProt ID | P5CR2_HUMAN | |
---|---|---|
UniProt AC | Q96C36 | |
Protein Name | Pyrroline-5-carboxylate reductase 2 | |
Gene Name | PYCR2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 320 | |
Subcellular Localization | Cytoplasm . Mitochondrion . | |
Protein Description | Housekeeping enzyme that catalyzes the last step in proline biosynthesis. In some cell types, such as erythrocytes, its primary function may be the generation of NADP(+). Can utilize both NAD and NADP. Has higher affinity for NADP, but higher catalytic efficiency with NADH. [PubMed: 2722838] | |
Protein Sequence | MSVGFIGAGQLAYALARGFTAAGILSAHKIIASSPEMNLPTVSALRKMGVNLTRSNKETVKHSDVLFLAVKPHIIPFILDEIGADVQARHIVVSCAAGVTISSVEKKLMAFQPAPKVIRCMTNTPVVVQEGATVYATGTHALVEDGQLLEQLMSSVGFCTEVEEDLIDAVTGLSGSGPAYAFMALDALADGGVKMGLPRRLAIQLGAQALLGAAKMLLDSEQHPCQLKDNVCSPGGATIHALHFLESGGFRSLLINAVEASCIRTRELQSMADQEKISPAALKKTLLDRVKLESPTVSTLTPSSPGKLLTRSLALGGKKD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSVGFIGAG ------CCCCCCCHH | 30.83 | 20071362 | |
2 | Acetylation | ------MSVGFIGAG ------CCCCCCCHH | 30.83 | 19413330 | |
13 | Phosphorylation | IGAGQLAYALARGFT CCHHHHHHHHHHCCC | 15.67 | 29496907 | |
20 | Phosphorylation | YALARGFTAAGILSA HHHHHCCCHHHHHHH | 20.58 | 24114839 | |
26 | Phosphorylation | FTAAGILSAHKIIAS CCHHHHHHHHHHHHC | 26.80 | 27251275 | |
33 | Phosphorylation | SAHKIIASSPEMNLP HHHHHHHCCCCCCCC | 35.70 | 20068231 | |
34 | Phosphorylation | AHKIIASSPEMNLPT HHHHHHCCCCCCCCH | 18.83 | - | |
41 | Phosphorylation | SPEMNLPTVSALRKM CCCCCCCHHHHHHHH | 30.20 | 28348404 | |
43 | Phosphorylation | EMNLPTVSALRKMGV CCCCCHHHHHHHHCC | 24.86 | 28348404 | |
47 | Ubiquitination | PTVSALRKMGVNLTR CHHHHHHHHCCCCCC | 40.64 | - | |
47 | Succinylation | PTVSALRKMGVNLTR CHHHHHHHHCCCCCC | 40.64 | 27452117 | |
47 | Malonylation | PTVSALRKMGVNLTR CHHHHHHHHCCCCCC | 40.64 | 26320211 | |
94 | Phosphorylation | QARHIVVSCAAGVTI CHHHHHHCCCCCCCH | 6.27 | 29083192 | |
100 | Phosphorylation | VSCAAGVTISSVEKK HCCCCCCCHHHHHHH | 17.77 | 29083192 | |
102 | Phosphorylation | CAAGVTISSVEKKLM CCCCCCHHHHHHHHH | 20.97 | 29083192 | |
103 | Phosphorylation | AAGVTISSVEKKLMA CCCCCHHHHHHHHHH | 30.37 | 29083192 | |
107 | Ubiquitination | TISSVEKKLMAFQPA CHHHHHHHHHHCCCC | 29.95 | - | |
109 | Sulfoxidation | SSVEKKLMAFQPAPK HHHHHHHHHCCCCCE | 4.88 | 21406390 | |
116 | Ubiquitination | MAFQPAPKVIRCMTN HHCCCCCEEEEECCC | 53.02 | 21890473 | |
228 | Acetylation | EQHPCQLKDNVCSPG CCCCCCCCCCEECCC | 22.75 | 25953088 | |
233 | Phosphorylation | QLKDNVCSPGGATIH CCCCCEECCCCHHEH | 23.46 | 27050516 | |
238 | Phosphorylation | VCSPGGATIHALHFL EECCCCHHEHHHHHH | 19.30 | 20873877 | |
252 | Phosphorylation | LESGGFRSLLINAVE HHCCCCHHHHHHHHH | 25.85 | 24719451 | |
261 | Phosphorylation | LINAVEASCIRTREL HHHHHHHHHHCHHHH | 9.14 | 21712546 | |
262 | Glutathionylation | INAVEASCIRTRELQ HHHHHHHHHCHHHHH | 2.92 | 22555962 | |
265 | Phosphorylation | VEASCIRTRELQSMA HHHHHHCHHHHHHHH | 14.48 | 24719451 | |
276 | Ubiquitination | QSMADQEKISPAALK HHHHCHHCCCHHHHH | 42.74 | - | |
276 | Acetylation | QSMADQEKISPAALK HHHHCHHCCCHHHHH | 42.74 | 19829087 | |
283 | 2-Hydroxyisobutyrylation | KISPAALKKTLLDRV CCCHHHHHHHHHHHH | 38.70 | - | |
283 | Ubiquitination | KISPAALKKTLLDRV CCCHHHHHHHHHHHH | 38.70 | - | |
284 | Ubiquitination | ISPAALKKTLLDRVK CCHHHHHHHHHHHHC | 45.30 | - | |
291 | Ubiquitination | KTLLDRVKLESPTVS HHHHHHHCCCCCCCC | 47.64 | - | |
294 | Phosphorylation | LDRVKLESPTVSTLT HHHHCCCCCCCCCCC | 35.99 | 24732914 | |
296 | Phosphorylation | RVKLESPTVSTLTPS HHCCCCCCCCCCCCC | 36.05 | 24732914 | |
298 | Phosphorylation | KLESPTVSTLTPSSP CCCCCCCCCCCCCCC | 21.85 | 24732914 | |
299 | Phosphorylation | LESPTVSTLTPSSPG CCCCCCCCCCCCCCC | 30.25 | 24732914 | |
301 | Phosphorylation | SPTVSTLTPSSPGKL CCCCCCCCCCCCCCH | 22.63 | 30266825 | |
303 | Phosphorylation | TVSTLTPSSPGKLLT CCCCCCCCCCCCHHH | 43.88 | 30266825 | |
304 | Phosphorylation | VSTLTPSSPGKLLTR CCCCCCCCCCCHHHH | 38.58 | 29255136 | |
307 | Ubiquitination | LTPSSPGKLLTRSLA CCCCCCCCHHHHHHH | 43.65 | 21890473 | |
307 | Acetylation | LTPSSPGKLLTRSLA CCCCCCCCHHHHHHH | 43.65 | 25953088 | |
310 | Phosphorylation | SSPGKLLTRSLALGG CCCCCHHHHHHHCCC | 28.75 | 28152594 | |
312 | Phosphorylation | PGKLLTRSLALGGKK CCCHHHHHHHCCCCC | 16.86 | 23312004 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
304 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of P5CR2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of P5CR2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A4_HUMAN | APP | physical | 21832049 | |
MYO1F_HUMAN | MYO1F | physical | 26186194 | |
MY18A_HUMAN | MYO18A | physical | 26186194 | |
SKA3_HUMAN | SKA3 | physical | 26186194 | |
NUDT5_HUMAN | NUDT5 | physical | 26186194 | |
SKA1_HUMAN | SKA1 | physical | 26186194 | |
AHNK2_HUMAN | AHNAK2 | physical | 26186194 | |
P5CR3_HUMAN | PYCRL | physical | 26186194 | |
P5CR1_HUMAN | PYCR1 | physical | 26344197 | |
SKA3_HUMAN | SKA3 | physical | 28514442 | |
SKA1_HUMAN | SKA1 | physical | 28514442 | |
NUDT5_HUMAN | NUDT5 | physical | 28514442 | |
MY18A_HUMAN | MYO18A | physical | 28514442 | |
MYO1F_HUMAN | MYO1F | physical | 28514442 | |
AHNK2_HUMAN | AHNAK2 | physical | 28514442 | |
P5CR3_HUMAN | PYCRL | physical | 28514442 | |
AHNK_HUMAN | AHNAK | physical | 28514442 |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB00172 | L-Proline |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-303 AND SER-304, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-304, AND MASSSPECTROMETRY. |